ACS 2014 ENTREPRENEUR SUMMIT DRAFT

Transcription

1 ACS 2014 ENTREPRENEUR SUMMIT DRAFT National Education Association American Chemical Society Washington, DC October 13-14, 2014 Theme: Customer Focus Provide entrepreneurs with a deeper understanding of commercialization challenges and the interplay between start-ups, government, financiers, and partners toward the successful commercialization of chemistry-based technologies. _ 7:00AM 8:15AM DAY 1 Wednesday, October 13, 2014 National Education Association Auditorium th Street, NW Washington DC Registration (Lobby)/Continental Breakfast 8:15AM 8:20AM Summit Opening & Welcoming Remarks ACS s Executive Director & CEO, Madeleine Jacobs, will open the Summit with welcoming remarks. 8:20AM 8:30AM Summit Overview & Keynote Introduction ACS s Entrepreneurial Initiative Program Director, Dr. David Harwell, will provide an overview of the ACS Entrepreneurial Resources Center, the Summit, and introduce today s keynote speaker, Dr. Carl J. Schramm. 8:30AM 9:30AM Keynote Speaker An internationally recognized leader in entrepreneurship, innovation and economic growth, Dr. Schramm will discuss changing paradigms in entrepreneurship and the emerging emphasis on customer needs. Dr. Carl J. Schramm, Professor at Syracuse University, former President of the Ewing Marion Kauffman Foundation 9:30AM 10:00AM BREAK & NETWORKING (NEA Auditorium Foyer) 10:00AM 11:00AM Minorities in Entrepreneurship What s Next This session focuses on the achievements and challenges facing minority chemical entrepreneurs. Dr. McCrary will discuss what lies ahead for their greater success. Dr. Victor McCrary, Vice President for Research and Development, Morgan State University 11:00AM 12:00PM Women in Entrepreneurship the Diana Project

2 ACS Executive Director & CEO, Madeleine Jacobs, interviews Dr. Greene about the progress that has been made and the remaining challenges facing women and minorities in entrepreneurship. Dr. Patricia G. Greene, Paul T. Babson Chair in Entrepreneurial Studies at Babson College and National Academic Director for Goldman Sachs 10,000 Small Businesses initiative 12:00PM 1:30PM 01:30PM 2:30PM NETWORKING LUNCH (ACS Hach Headquarters Marvel Halls) I-Corps What s Next The NSF Innovation Corps (I-Corps ) is a set of activities and programs that prepare scientists and engineers to extend their focus beyond the laboratory and broaden the impact of selected, NSF-funded, basic-research projects. Combining experience and guidance from established entrepreneurs with a targeted curriculum, I- Corps is a public-private partnership program that teaches grantees to identify valuable product opportunities that can emerge from academic research, and offers entrepreneurship education to faculty and student participants. This session will provide an overview of the I-Corps program and its accomplishments to date. Dr. Grace Wang, Deputy Assistant Director, Directorate for Engineering, National Science Foundation Grace Wang was named Deputy Assistant Director for Engineering at the National Science Foundation in July Prior to that, Grace was the Division Director of the Division of Industrial Innovation and Partnerships (IIP) at NSF since February Grace joined NSF in June 2009 as a Program Director for the SBIR/STTR Program. She also served as the Cluster Leader for the Nanotechnology, Advanced Materials and Manufacturing (NM) Cluster in SBIR/STTR Program. Before joining NSF, Grace was a Senior Development Scientist at Hitachi, where she led a team to successfully develop and launch a few generations of products into the market. While in Hitachi, Grace also led task forces both in the US and overseas that identified and executed effective and viable solutions to major technical crises, and helped mitigate impact on revenue generation. Grace started her career as an Advisory Development Scientist at IBM. Grace is the recipient of many leadership and technical achievement awards. Grace holds a Ph.D. in Materials Science and Engineering from Northwestern University. Dr. Rathindra DasGupta, Program Director, Innovation Corps (I-Corps), National Science Foundation Dr. DasGupta joined the National Science Foundation (NSF) in June 2006 as a Program Director in the Division of Industrial Innovation and Partnerships, Small Business Innovation Research Program. Dr. DasGupta is currently the lead program director for the Innovation Corps (I-Corps) program. Before joining NSF, Dr. DasGupta was the chief scientist for CONTECH Division, SPX Corporation. Prior to joining the industry, Dr. DasGupta held various professorships at the Milwaukee School of Engineering, UW-Madison, UW-Milwaukee, and Western Michigan University. Dr. DasGupta has received multiple awards and honors and has published numerous papers, has presented at various international and domestic conferences, and has five patents to his credit. In the summer of 1985, Dr. DasGupta was also invited as a visiting scientist to China Steel Corporation in Kaoshiung, Taiwan. 2:30PM 3:30PM New Approaches to Innovation Disruptive Technology Health Institute Abandoning the old innovation model of launching a great idea into market is being challenged at Carnegie Mellon University s Disruptive Technology Health Institute. What can be learned from information technology and data mining practices that can be useful and disruptive for chemical entrepreneurs taking a market-first approach? Lynn M. Brusco, Executive Director, Disruptive Technology Health Institute, Carnegie Mellon University

3 3:30PM 3:45PM BREAK & NETWORKING (NEA Auditorium Foyer) 3:45PM 4:30PM Challenges & Determination Lessons from an Entrepreneur Dr. David Harwell, ACS s Administrator for the ACS Entrepreneurship Initiative, interviews Dr. Serrero about the challenges she faced and the lessons she learned from starting her own company based on her discovery of the GP88/PGRN growth factor protein and her pioneering research demonstrating its importance in the tumorigenesis of many cancers. Dr. Ginette Serrero, CEO and Co-Founder of A&G Pharmaceuticals PHOTO & BIO GINETTA 04:30PM 5:30PM Unique Partnerships in Innovation What is the latest in innovation from urban research parks? How is the nation s oldest urban research park responding to the changes in innovation over the years? And, what does the future look like for research parks as the process of innovation changes. Dr. Stephen S. Tang, President & CEO, University City Science Center PHOTO & BIO STEPHEN TANG 5:30PM 7:00PM EVENING NETWORKING RECEPTION (ACS Hach Headquarters Marvels)

4 7:00AM 8:30AM _ DAY 2 Tuesday, October 14, 2014 _ (ACS Hach Headquarters Marvel Halls) Registration (Lobby)/Continental Breakfast (TBD) 8:30AM 8:40AM Welcoming Remarks ACS s Executive Director & CEO, Madeleine Jacobs, will open the Summit with welcoming remarks. 8:40AM 9:30AM Getting Funded ACS's Innovation Counsel and Administrator to the ACS Entrepreneurial Resources Center, Kenneth Polk, interviews Dr. Mark Vreeke about his co-founding of the Chemical Angel Network; his experiences with the challenges entrepreneurs face as they navigate investment discussions; and some pragmatic dos and don'ts that may help you, the entrepreneur, along a traditional funding path. To give us a perspective on emerging funding, Dr. Polk will interview Scott Popma about the latest in crowd funding activities as an alternative source of funding. Dr. Mark Vreeke, Co-Founder, Chemical Angel Network Scott J. Popma: Founder, Ballast IP Capital Group Scott J. Popma is the founder of Ballast IP Capital Group and former partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP s Washington, D.C. office. He is an industry leader on issues surrounding the intersection of intellectual property law and emerging technologies and advises clients on a wide variety of IP legal issues including licensing, crowdfunding, crowdsourcing, freedom to operate, portfolio and landscape analysis, litigation strategy, and monetization. 9:30AM 10:30AM The Innovation Spotlight E. I. du Pont de Nemours and Company William D. Provine, Director, Science & Technology External Affairs, DuPont 10:30AM 11:00AM BREAK & NETWORKING (ACS Hach Headquarters Marvel Halls) 11:00AM 12:00PM Managing Risk & Opportunity Partners Ready to Assist Risk and opportunity go hand-in-hand. What is available to the chemical entrepreneurship from the risk management community that will help to broaden opportunities for growth? This panel discusses why and how insurance should be part of your operational planning. Moderator: Dr. Dennis Chamot, Member of the ACS Membership Insurance Board of Trustees, Past Member of the ACS Board of Directors, Retired Member of the National Academies of Science.

5 Dr. Henry Cifuentes, Hays Companies, Program Administrator for the ACS Professional Liability Insurance Program Mr. Richard Kissel, Partner, Kissel Pesce Hirsch & Wilmer, LLP, Claims Attorney for the ACS Professional Liability Plan for Lloyd s of London Mr. William Henson, Senior Select Customer Sales Representative, The Hartford, Key Staff Member of the ACS Commercial Business Insurance Plans Risk and opportunity go hand-in-hand. What is available to the chemical entrepreneurship from the risk management community that will help to broaden opportunities for growth? This panel discusses why and how insurance should be part of your operational planning. Moderator: Dr. Dennis Chamot, Member of the Board of Trustees, Group Insurance Plans for ACS Members. Dennis Chamot recently retired as Associate Executive Director of the Division on Engineering and Physical Systems of the National Research Council. He had served as a member of the Board of Directors of the American Chemical Society for ten years, and was a candidate for President-Elect of the ACS in He is a Fellow of the ACS and of the American Association for the Advancement of Science (AAAS). Dr. Chamot holds a Ph.D. (Chemistry) from the University of Illinois, and MBA from the Wharton School of the University of Pennsylvania. Mr. Henry Cifuentes, Hays Companies, Program Administrator/Underwriter for the ACS Program. Professional Liability Insurance Henry Cifuentes has thirteen years of Underwriting, Risk Management and Affinity Program underwriting and development experience. Henry is currently Vice President at Hays Companies of Washington, D.C. He is responsible for casualty underwriting, business development and servicing a wide variety of affinity insurance programs and policyholders. Henry started his career at AON of Washington, D.C. in the national programs division as an underwriter. Henry has successfully managed multiple national affinity programs and assisted in developing others from the ground up. Henry has specialized in underwriting and providing risk management services across many professional service industries including Environmental, Health & Safety, Technology, Life Sciences, Accounting, Legal, and Engineering. Henry is also involved in the day-to-day operations and advising policyholders of their coverage terms and options. Henry is responsible for working with national association clients to develop and maintain a high value insurance program. Henry Cifuentes graduated with a B.S. Management from Virginia Tech and with an MBA from Marymount University. Mr. Richard Kissel, Partner, Kissel Hirsch & Wilmer, LLP, Claims Attorney for the ACS Professional Liability Plan for Lloyd s of London. Mr. Kissel is a founding member of Kissel Hirsch & Wilmer and has represented the interests of insurers and reinsurers for over 30 years. Rich graduated with honors from Syracuse University College of Law, where he was on the Moot Court Board, for which he received awards. He was also a Graduate Teaching Assistant in Legal Research and Writing. Rich graduated with honors from Boston University School of Management, where he majored in accounting. Mr. William Henson, Senior Sales Representative, The Hartford. Chip Henson is a graduate of Virginia Tech where he received a Bachelor of Science in Marketing. Following graduation in 2000, Chip entered the insurance industry with Liberty Mutual Insurance in sales and marketing. In 2008 Chip went to work for a large national insurance brokerage, and ultimately transitioned to his current marketing role with The Hartford in :00PM 1:00PM 01:00PM 01:45PM NETWORKING LUNCH (ACS Hach Headquarters Marvel Halls) Chemical Innovation and Entrepreneurship This session discusses the role that corporate venture partners can play in the development of promising chemical technologies through expertise, development arrangements, and funding. Moderator: Dr. Magid Abou-Gharbia, Associate Dean for Research, Laura H. Carnell Professor & Director of the Moulder Center for Drug Discovery Research, School of Pharmacy, Temple University Dr.Amy Ripka, Associate VP of Program Management, SAl Life Science Limited Dr. Dan Daly, Director of the AIME Center, University of Alabama

6 PHOTO & BIO MAGID, AMY, DAN 01:45PM 02:30PM Validating the Technology Role of Proof-of-Concept (POC) Centers Proof-of-Concept Centers play a crucial role in validating the value proposition. The ability to create a prototype of the invention and test the prototype in a statistically designed experiment in which the differentiating qualities of the innovation can be demonstrated against competitive technologies is of great value to potential investor s assessment. Moderator: Dr. Dan Daly, Director of the AIME Center, University of Alabama Julie Weber, Battery Innovation Center Andrea Wesser, MegaWatt Ventures Bryan Borlik, Director of Performance and National Programs EDA, Richard Kordal, PhD, Director, Office of Intellectual Property and Commercialization Louisiana Tech University 2:30PM 2:45PM BREAK & NETWORKING (ACS Hach Headquarters Marvel Halls) 02:45PM 03:45PM Commercial Partners The Best Way to a Deal This session discusses the driving needs for Big Pharma to collaborate more with external academics, entrepreneurs and biotechs on the deployment of novel chemistry platform technologies, development of novel therapeutic compounds and lower cost pharmaceuticals. The focus would be on how academics, entrepreneurs and small biotech s should best go about making deals happen with pharma in the new biotech era. Moderator: Dr. Avi Spier, Director, Strategic Alliances, Novartis Institutes for BioMedical Research, Inc. Dr. Julius Knowles, Partner, Innovation Fund, Partners HealthCare Dr. Paul Stead, Director - Business Development, Platform Technology and Science, GSK Dr. Jonas Niaura, Director, Search and Evaluation, AstraZeneca Dr. Scott Forrest, VP, Business Development, The Scripps Research Institute Dr. Venkat Reddy, Senior Director, Strategic Alliances and Partnerships, Centers for Therapeutic Innovation (CTI) Pfizer Inc. 03:45PM 05:00PM Develop the Customer, Then the Business This presentation will provide entrepreneurs with real experiences and strategies for finding and developing customers, determining their ability and willingness to pay, and building customer relationships. Moderator: Lynette Horton, former Managing Director, Harbert Management Corporation, Marketing & Investor Relations Ron Kreis, Founder & President, BiMax, Inc. Dr. Ronald Pierantozzi, Managing Partner, Cameron and Associates Dr. William Armiger, President, BioChemInsights, Inc. Dr. Ronald Pierantozzi, Managing Partner, Cameron and Associates Dr. Pierantozzi,a technologist and inventor (Ph.D. Chemistry, 32 US Patents in the Chemicals and Materials Domain) bridges the space between business strategy and technology. He has developed business opportunities for both large and

7 small companies, serving as CEO of PPT Research, a high tech materials concern, board member for Primet Precision Materials and an advisor to the Fortune 100 as well as start-ups. He continues to lecture on corporate entrepreneurship and innovation at The Wharton Business School, RPI Lally School of Management, Babson college and the Danish Technical University. He was also an executive with Air Products and Chemicals where he was responsible for Corporate Venturing and innovation. He has co-authored articles in both HBR and SMR. Dr, Ron Kreis, Founder & President, BiMax, Inc. Founded BiMax over 20 years ago. has grown the company from 2 to over 70 people today operating their chemical plant 24x7 making specialty polymers and monomers. They are a major supplier to the contact lens business world-wide as well as the developer and supplier of coating for cell phones and computer screens. Ron received his PhD in Chemistry from the University of Delaware. After 14 at Alcolac, Inc where he was Vice President of Technology, he started Bimax. His company has grown organically and occupies a unique niche in the specialty chemicals business. He will bring to the panel a wealth of experience in building an entrepreneurial chemical business. 05:00PM Summit Closing & Concluding Remarks ACS's Innovation Counsel and Administrator to the ACS Entrepreneurial Resources Center Kenneth Polk concludes the Summit with closing remarks.